Display options
Share it on

J Ophthalmol. 2015;2015:974870. doi: 10.1155/2015/974870. Epub 2015 Oct 04.

Clinical Outcome of Hypertensive Uveitis.

Journal of ophthalmology

Deborah Lewkowicz, François Willermain, Lia Judice Relvas, Dorine Makhoul, Sarah Janssens, Xavier Janssens, Laure Caspers

Affiliations

  1. CHU Saint-Pierre, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium ; CHU Brugmann, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium.
  2. CHU Saint-Pierre, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium.

PMID: 26504598 PMCID: PMC4609461 DOI: 10.1155/2015/974870

Abstract

Purpose. To review the clinical outcome of patients with hypertensive uveitis. Methods. Retrospective review of uveitis patients with elevated intraocular pressure (IOP) > 25 mmHg and >1-year follow-up. Data are uveitis type, etiology, viral (VU) and nonviral uveitis (NVU), IOP, and medical and/or surgical treatment. Results. In 61 patients, IOP values are first 32.9 mmHg (SD: 9.0), highest 36.6 mmHg (SD: 9.9), 3 months after the first episode 19.54 mmHg (SD: 9.16), and end of follow-up 15.5 mmHg (SD: 6.24). Patients with VU (n = 25) were older (50.6 y/35.7 y, p = 0.014) and had more unilateral disease (100%/72.22%  p = 0.004) than those with NVU (n = 36). Thirty patients (49.2%) had an elevated IOP before topical corticosteroid treatment. Patients with viral uveitis might have higher first elevated IOP (36.0/27.5 mmHg, p = 0,008) and maximal IOP (40.28/34.06 mmHg, p = 0.0148) but this was not significant when limited to the measurements before the use of topical corticosteroids (p = 0.260 and 0.160). Glaucoma occurred in 15 patients (24.59%) and was suspected in 11 (18.03%) without difference in viral and nonviral groups (p = 0.774). Conclusion. Patients with VU were older and had more unilateral hypertensive uveitis. Glaucoma frequently complicates hypertensive uveitis. Half of the patients had an elevated IOP before topical corticosteroid treatment.

References

  1. Surv Ophthalmol. 1997 Mar-Apr;41(5):361-94 - PubMed
  2. Am J Ophthalmol. 1975 Sep;80(3 Pt 1):425-9 - PubMed
  3. Ocul Immunol Inflamm. 2008 Jan-Feb;16(1):1-2 - PubMed
  4. Curr Opin Ophthalmol. 2004 Apr;15(2):136-40 - PubMed
  5. Clin Exp Ophthalmol. 2012 May-Jun;40(4):341-9 - PubMed
  6. Ocul Immunol Inflamm. 2009 May-Jun;17(3):160-9 - PubMed
  7. Ophthalmology. 2002 Aug;109(8):1532-7 - PubMed
  8. Am J Ophthalmol. 2005 Sep;140(3):509-16 - PubMed
  9. Ocul Immunol Inflamm. 2013 Jun;21(3):192-6 - PubMed
  10. Medicine (Baltimore). 2001 Jul;80(4):263-70 - PubMed
  11. Acta Ophthalmol Scand. 2000 Oct;78(5):576-9 - PubMed
  12. JAMA Ophthalmol. 2014 Jul;132(7):859-65 - PubMed
  13. Am J Ophthalmol. 2008 May;145(5):834-40 - PubMed
  14. Surv Ophthalmol. 1992 May-Jun;36(6):395-410 - PubMed
  15. J Fr Ophtalmol. 2011 Mar;34(3):157-63 - PubMed
  16. J Fr Ophtalmol. 2003 Oct;26 Spec No 2:S10-2 - PubMed
  17. Ophthalmol Clin North Am. 2005 Sep;18(3):421-30, vii - PubMed
  18. Ophthalmology. 1987 Oct;94(10):1242-8 - PubMed
  19. Int Ophthalmol. 2010 Oct;30(5):501-9 - PubMed
  20. Ophthalmology. 1984 Oct;91(10):1247-52 - PubMed
  21. J Glaucoma. 2004 Dec;13(6):461-5 - PubMed
  22. Surv Ophthalmol. 2013 Jan-Feb;58(1):1-10 - PubMed
  23. Curr Opin Ophthalmol. 2011 Nov;22(6):483-8 - PubMed
  24. Ophthalmology. 2000 Jun;107(6):1164-70 - PubMed
  25. Surv Ophthalmol. 2008 Nov;53 Suppl1:S17-32 - PubMed
  26. Ophthalmic Res. 2011;46(1):9-12 - PubMed
  27. Orphanet J Rare Dis. 2012 Apr 12;7:20 - PubMed
  28. Graefes Arch Clin Exp Ophthalmol. 2009 Jun;247(6):775-80 - PubMed
  29. Am J Ophthalmol. 2009 Aug;148(2):207-213.e1 - PubMed
  30. Middle East Afr J Ophthalmol. 2009 Oct;16(4):239-44 - PubMed
  31. Int Ophthalmol. 2010 Apr;30(2):191-4 - PubMed
  32. Ophthalmology. 2011 Oct;118(10):1905-10 - PubMed
  33. Br J Ophthalmol. 1990 Apr;74(4):223-7 - PubMed

Publication Types